Knowledge Center

Patent / Nov 13, 2008

Methods and intermediates for synthesis of selective dpp-iv inhibitors

Authors:
  • Emilia Leitao
  • David Alan Campbell
  • Zhen-Ping Wu
  • Peng Wang
Source:
WO2008109681A3

Methods and intermediates for the synthesis of selective inhibitors of dipeptidyl peptidase IV (DPP-IV) are provided. Coupling of a carboxylate salt with a boro-proline derivative provides a protected form of a DPP-IV inhibitor, which may be deblocked to yield the medicinal compound. The carboxylate salt can be a crystalline form of a sodium salt or a dicyclohexylammonium salt. The inhibitor can be used in the treatment of diabetes.

Also in the Knowledge Center

Related Content

Drug delivery platforms

ËÄÉ«AV has unique capabilities and expertise in solubility enhancement, lung delivery, modified release and taste-masking applications.

Page
Read more

Inhalation devices

ËÄÉ«AV’s inhalers offer our business partners access to simple, multipurpose, easy to use, globally competitive alternatives for inhalation delivery devices.

Page
Read more

Drug Product Manufacturing

To extend ËÄÉ«AV further we are now able to offer clinical supplies manufacturing for drug products.

Page
Read more